Search Results

Check out our GPCR coverage for this week. GPCR Symposia Our upcoming symposium on March 15th is about GPCR activation and signaling. Activation and Signaling GPCR signaling bias: an emerging framework for opioid drug development Structural at the plasma membrane Industry News Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop GPCR Ecosystem

GPCR Symposia Mark your calendars! GPCR University Great News! The Dr. GPCR Partnered Events April 22 - 23, 2024 | Endocrine Metabolic GPCRs Join the Endocrine Metabolic GPCRs Let’s dive into the Classified GPCR News from February 26th to March 3rd, 2024 Adhesion GPCRs The repertoire GPCR Ecosystem

February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech believes the area is still ripe for development, and it now has The company's co-founder, GPCR pioneer and Nobel laureate Robert Lefkowitz, M.D., has 50 years of experience Read more at the source #DrGPCR #GPCR #IndustryNews

network located on intracellular loop 2 that is subject to RNA editing, which differentially affects GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it! GPCR Newsletter! Dive into the Classified GPCR News from September 18th to 24th, 2023. GPCR Activation and Signaling Rules and mechanisms governing G protein coupling selectivity of GPCRs Papers opnMe GPCR Route 66+ project. GPCR Ecosystem

Join us for this week’s update, where you’ll find all the latest breakthroughs and exciting developments in GPCR research. GPCR courses GPCR Forum Initiate a vibrant conversation or seek assistance GPCR Events to keep you News Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments Five protein-design questions that Events, Meetings, and Webinars NEW November 18 - 20, 2024 | 7th CB1 & CB2 Targeting Drug Development

Topics: New cellular assays, real-time kinetics, and unique GPCR behaviors. 🔥 Why You Should Enroll Exclusive Deal for Scientists Residing and Working in Developing Nations If you live and work  in a developing This technique for studying cell receptors could have sweeping implications for drug development DeepCure value of GPCR cell-based assays in drug discovery NEW September 22, 2024 | Biomolecular Horizons 2024 of Neurological Disease s Activation of GPR55 alleviates neuropathic pain and chronic inflammation Developmental

that the affinity of Fzd for Dvl was not affected by Wnt ligands, in contrast to other members of the GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video GPCR Newsletter for more insights! GPCR Latrophilin, an adhesion GPCR with galactose-binding lectin domain involved in the innate immune Program Acquired by Vertex Call for GPCR Papers opnMe GPCR Route 66+ project. GPCR Ecosystem

Get ready for an expedition, GPCR explorers! Welcome back to your weekly GPCR quest! biotechs hacking the cell signaling pathway From Structure to Solution: How Structural Biology Informs the Development Board GLP-1s like Ozempic are among the most important drug breakthroughs ever Goldman-backed drug developer Emerging Voices in GPCR Biology in Special Issue of Molecular Pharmacology GPCR Events, Meetings, and

sweet taste receptor is a heterodimeric receptor composed of two distinct G-protein-coupled receptors (GPCRs The TAS1R2 and TAS1R3 subunits are members of a small family of class C GPCRs whose members share the However, cellular assays, molecular docking and site-directed mutagenesis studies have revealed that investigated whether the impact of point mutations, already shown to have deleterious effects on cellular assays Read more at the source #DrGPCR #GPCR #IndustryNews

Hello GPCR enthusiasts! Check out the latest advancements in GPCR studies. Save the date! GPCR Newsletter! chemical biology: a mini-review YAP/TAZ: Molecular pathway and disease therapy Primary cilia in skeletal development Business Update for Second Quarter and First Half of 2023 Novo Nordisk to acquire Inversago Pharma to develop GPCR Ecosystem

October 2022 "Understanding the activation of G protein-coupled receptors (GPCRs) is of paramount importance Although many cardiovascular GPCRs have been extensively studied as model receptors for decades, new As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation nanobodies have been adopted to elucidate the structure, pharmacology, and signaling of cardiovascular GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews

the fascinating world of GPCRs. GPCR Symposium on 'GPCRs as Therapeutic Modalities'. GPCR Newsletter! Remember to check out the weekly Classified GPCR News from August 14 to 20, 2023 Adhesion GPCRs Amelioration GPCR Ecosystem

are small-lipidated peptides designed from the intracellular loops of G protein-coupled receptors (GPCRs ) that act in an allosteric manner to modulate the activity of GPCRs. the past 2 decades, pepducins have progressed initially from pharmacologic tools used to manipulate GPCR We will discuss the historic context of pepducin development for each receptor, as well as the structural Read more at the source #DrGPCR #GPCR #IndustryNews

2022 Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR the Sosei Heptares compound library for its industry-leading biology platform to identify potential GPCR targets and advance the development of new gastrointestinal therapeutics Tokyo, Japan, Cambridge, UK entered a strategic research collaboration to identify and validate novel G protein-coupled receptor (GPCR drug discovery programs in the area of gastrointestinal diseases. " Read more at the source #DrGPCR #GPCR

GPCR Ecosystem. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. NEW FREE Symposium - IPI Surfacing (June 15, 2023) Training School on “Cell-based assays to study Adhesion GPCR function". GPCR Ecosystem

Read more at the source #DrGPCR #GPCR #IndustryNews

Read more at the source #DrGPCR #GPCR #IndustryNews

release of these hormones in the adrenals is tightly regulated by adrenal G protein-coupled receptors (GPCRs In this review, we discuss important aspects of adrenal GPCR signaling and regulation, as they pertain modulation of cardiac function in the context of chronic HF, by focusing on the 2 best studied adrenal GPCR the β-arrestins in the adrenals, 2 protein families that regulate the signaling and functioning of GPCRs Read more at the source #DrGPCR #GPCR #IndustryNews

drug discovery - Design Pharmaceuticals Call for GPCR Papers GPCRs: Signal Transduction. GPCR Events, Meetings, and Webinars NEW 4th ERNEST GPCR ECI zoominar. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. NEW Training School on “Cell-based assays to study Adhesion GPCR function". GPCR Ecosystem

orphan and constitutively active receptor belonging to the superfamily of G-Protein Coupled Receptors (GPCRs expression was evaluated at gene and protein level, the signalling pathway was investigated by an IP1 assay Cell migration was detected by the Boyden chamber migration assay, performed on macrophages derived from Read more at the source #DrGPCR #GPCR #IndustryNews

Welcome, GPCR enthusiasts! This week's GPCR papers feature a publication by Dr. Robert J Lefkowitz. GPCR Symposium on Structural and Molecular Insights on GPCR Activation! GPCR Newsletter for updates! Hijacking of GPCRs and RTKs by pathogens. GPCR Ecosystem

Hello GPCR enthusiasts! We're here to share the latest GPCR news with you. Congratulations to Dr. GPCR Symposium on Structural and Molecular Insights on GPCR Activation is quickly approaching! GPCR Newsletter for updates! Structural and Molecular Insights into GPCR Function Dual mechanisms of cholesterol-GPCR interactions GPCR Ecosystem

transcription is endocytosis-dependent in primary hepatocytes "A number of G protein-coupled receptors (GPCRs activation by glucagon within 5 min and transit via EEA1-marked endosomes shown previously to be sites of GPCR Read more at the source #DrGPCR #GPCR #IndustryNews

Read more at the source #DrGPCR #GPCR #IndustryNews

August 2022 "The cannabinoid CB1 receptor is the most abundant G protein coupled receptor (GPCR) in A variety of ligands for CB1 receptors have been developed as promising drug candidates for the treatment These advances have paved the way for development of novel ligands for different therapeutic applications Guided Pharmacology of Membrane Proteins (BJP 75th Anniversary). " Read more at the source #DrGPCR #GPCR

Good day, GPCR folks! Take advantage of our GPCR highlights of the week. Dr. Hannes Schihada and his lab team developed fluorescent analogues for real-time binding studies of orphan GPCR Symposium for the year on GPCRs in Immunology and Oncology! signalling molecule to exert direct functional effects in primary cultures of osteoblasts and osteoclasts Development NEW Post-Doctoral Associate NEW Team Leader Antibody Discovery Staff Scientist (AC-TAP) in Database Development

August 2022 RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. GPCRs are involved in a variety of physiological and pathophysiological processes. So far, numerous therapeutics targeting GPCRs have been developed, with a focus on small molecules and Recently, functional autoantibodies targeting GPCRs have been associated with various disease-specific Read more at the source #DrGPCR #GPCR #IndustryNews

Grab your flux capacitors, GPCR time travelers! GPCR University 🎥 Recorded GPCR Courses and Symposia / Summit 💲 Special Pricing on GPCR courses GPCR community members Join the GPCR fan club and geek out with fellows! So much more to come! Biological Keys to Medical Therapies From Structure to Solution: How Structural Biology Informs the Development Activation and Signaling Exploring Bias in GPCR Signaling and its Implication in Drug Development: A